마이페이지
| 번호 | 내용 | 작성일 |
|---|---|---|
| 22 | Risk-Based Approach to 21 CFR Part 11 | 2003-02-24 |
| 21 | Pharmaceutical cGMPs for the 21st Century | 2003-02-23 |
| 20 | Pharmaceutical cGMP Initiative Questions and Answe | 2003-01-25 |
| 19 | An Overview of the FDA’s PAT Initiative | 2003-01-23 |
| 18 | How to Approach FDA Validation | 2003-01-22 |
| 17 | KGMP 해설서- 정오표 | 2002-12-03 |
| 16 | Guidance_Bioavailability_Bioequivalence | 2002-08-25 |
| 15 | Development of Analytical Methods | 2002-08-24 |
| 14 | Stability testing of biotechnological/biological p | 2002-08-23 |
| 13 | 국가표준기본법시행령 | 2002-06-19 |
